| Literature DB >> 26430460 |
V Akbari1, H Mir Mohammad Sadeghi1, A Jafarian-Dehkordi1, C Perry Chou2, D Abedi1.
Abstract
Human epidermal growth factor receptor (HER) family plays an important role in various types of cancers. As a result, antibodies against HER and the mechanism of antigen-antibody binding action are under active investigation. We previously constructed a single-chain variable fragment (ScFv) against HER2, i.e. anti-Her2 ScFv, for expressing in the Escherichia coli. In the present study, we report the optimization of anti-Her2 ScFv expression in an E. coli host of BL21 (DE3) pLysS using response surface methodology based on tuning of three cultivation variables, including isopropyl-beta-D-thiogalactopyranoside (IPTG) concentration, temperature and post-induction time. A model for protein expression according to the Box-Behnken design predicted a maximal anti-Her2 ScFv expression at 37 °C, a post-induction time of 10.45 h and 0.75 mM IPTG. In addition, strategies based on inclusion body isolation and affinity chromatography were applied to purify anti-Her2 ScFv. The purity of the final product for inclusion bodies isolation and purification by Ni-NTA resin were 70 % and 95 %, respectively. The solubilization of the inclusion bodies was carried out using two denaturant agents, guanidine hydrochloride and urea. The present study showed that guanidine hydrochloride was more effective than urea in solubilizing the inclusion bodies.Entities:
Keywords: Antibody; Escherichia coli; Human epidermal growth factor receptor (HER); Response surface methodology; Single-chain variable fragment (ScFv)
Year: 2015 PMID: 26430460 PMCID: PMC4578215
Source DB: PubMed Journal: Res Pharm Sci ISSN: 1735-5362
Variables and levels used in the experimental design.
Box–Behnken experimental design of 3 factors and 3 levels.
ANOVA for Response Surface Quadratic Model.
Fig. 1Response surface of ScFv expression represents the interaction between two factors in the expression of ScFv (mg/l) by keeping other factor constant. a; IPTG concentration (mM) and time after induction (h), b; time after induction (h) and temperature (°C), c; IPTG concentration (mM) and temperature (°C).
Fig. 2Normal (%) probability plot of the ‘studentized’ residuals for the model of ScFv expression.
Fig. 3SDS–PAGE of primary isolation of ScFv expressed in E. coli strain BL21(DE3) pLysS in the form of inclusion bodies. Lane 1; molecular weight marker, lane 2; bacterial culture before induction, lane 3; bacterial culture after induction, lane 4; inclusion bodies fraction after centrifugation, lane 5; inclusion bodies fraction after Triton X-100 wash, lane 6; inclusion bodies fraction solubilized with GndHCl, lane 7; inclusion bodies fraction solubilized with Urea, lane 8; purified ScFv with Ni-NTA column.